Is There a Rationale for GnRH Analogue Therapy in Endometriosis?
This paper discusses diagnostic criteria and evaluation of medical therapy response for endometriosis, a common gynecological disease with ongoing debate about its pathogenesis and treatment.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This chapter discusses the rationale for GnRH analogue therapy in endometriosis by reviewing criteria used to diagnose endometriosis and to evaluate response to medical therapy, alongside ongoing controversies in the field’s understanding of pathogenesis and pathophysiology. It synthesizes prior evidence and frameworks for assessing therapeutic effects, emphasizing how outcomes are judged in studies of medical treatments. The main limitation is that, as a narrative review/chapter, it does not present new primary clinical data and instead highlights conceptual and methodological issues in evaluating treatments. Relevance to endometriosis: the paper is explicitly about endometriosis and the rationale for GnRH analogue therapy, including how diagnosis and treatment response evaluation criteria are discussed in that context.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Full text
3,970 characters
· extracted from
oa-doi-fallback
· 3 sections
· click to expand
Abstract
References
Keywords
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (14)
- Classification of endometriotic implants by morphologic appearance and capacity to synthesize prostaglandin F via openalex
- Estrogen and progestin receptors in endometriosis lesions: Comparison with endometrial tissue via openalex
- Etiology and pathophysiology of endometriosis. via openalex
- Histologic and Ultrastructural Changes in Human Endometriotic Implants Treated with the Antiprogesterone Steroid Ethylnorgestrienone (Gestrinone) During 2 Months via openalex
- Nonpigmented endometriosis: Clinical, laparoscopic, and pathologic definition via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- The morphologic effect of short-term medical therapy of endometriosis via openalex
- Ultrastructural Changes in Endometriotic Tissue During Danazol Treatment via openalex
- W2227993884 via openalex
- W1968557684 via openalex
- W2406830263 via openalex
- W2415755045 via openalex
- W170550312 via openalex
- W73242332 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00